These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD. Hudda Z; Flannery A; Teusink-Cross A; Davies SM; Khandelwal P Bone Marrow Transplant; 2024 Mar; 59(3):425-427. PubMed ID: 38182673 [No Abstract] [Full Text] [Related]
15. When is the best time and grade to start ruxolitinib in corticosteroid-refractory acute graft-versus-host-disease: A multi-center research. Ren J; Lin K; Xu J; Lu Q; Luo Y; Lin C; Lu J; Weng Y; Zhang Y; Chen Z; Gale RP; Hu J; Yang T Clin Transplant; 2024 Jan; 38(1):e15195. PubMed ID: 37987525 [TBL] [Abstract][Full Text] [Related]
16. The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study. Yang W; Zhu G; Qin M; Li Z; Wang B; Yang J; Wang T Drug Des Devel Ther; 2021; 15():743-752. PubMed ID: 33654380 [TBL] [Abstract][Full Text] [Related]
17. [The Clinical Observation with Ruxolitinib as Graft-Versus-Host Disease Prophylaxis for Children with Thalassemia after Unrelated or Haploidentical Allo-Hematopoietic Stem Cell Transplantation]. Chen YM; Hong XL; Lin JZ; Shi J; Lu QY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1586-1589. PubMed ID: 36208270 [TBL] [Abstract][Full Text] [Related]
18. Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients. Wei C; Zhang X; Liang D; Yang J; Du J; Yue C; Deng L Drug Des Devel Ther; 2021; 15():4875-4883. PubMed ID: 34880598 [TBL] [Abstract][Full Text] [Related]
19. Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia. Zhang B; Chen L; Zhou J; Zu Y; Gui R; Li Z; Wang J; Yu F; Zhang Y; Zhao H; Ji Z; Song Y Sci Rep; 2021 Apr; 11(1):8501. PubMed ID: 33875780 [TBL] [Abstract][Full Text] [Related]
20. Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease. Aslan Candır B; Yiğenoğlu TN; Kızıl Çakar M; Dal MS; Altuntaş F J Oncol Pharm Pract; 2022 Jun; 28(4):983-985. PubMed ID: 35019785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]